Literature DB >> 27931146

D-Cycloserine Restores Experience-Dependent Neuroplasticity after Traumatic Brain Injury in the Developing Rat Brain.

Naomi S Sta Maria1,2, Maxine L Reger1,3, Yan Cai1, Mary Anne T Baquing1,4, Floyd Buen1,5, Aditya Ponnaluri1,6, David A Hovda1,7, Neil G Harris1, Christopher C Giza1,8.   

Abstract

Traumatic brain injury (TBI) in children can cause persisting cognitive and behavioral dysfunction, and inevitably raises concerns about lost potential in these injured youth. Lateral fluid percussion injury (FPI) in weanling rats pathologically affects hippocampal N-methyl-d-aspartate receptor (NMDAR)- and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated glutamatergic neurotransmission subacutely within the first post-injury week. FPI to weanling rats has also been shown to impair enriched-environment (EE) induced enhancement of Morris water maze (MWM) learning and memory in adulthood. Recently, improved outcomes can be achieved using agents that enhance NMDAR function. We hypothesized that administering D-cycloserine (DCS), an NMDAR co-agonist, every 12 h (i.p.) would restore subacute glutamatergic neurotransmission and reinstate experience-dependent plasticity. Postnatal day 19 (P19) rats received either a sham or FPI. On post-injury day (PID) 1-3, animals were randomized to saline (Sal) or DCS. Firstly, immunoblotting of hippocampal NMDAR and AMPAR proteins were measured on PID4. Second, PID4 novel object recognition, an NMDAR- and hippocampal- mediated working memory task, was assessed. Third, P19 rats were placed in an EE (17 days), and MWM performance was measured, starting on PID30. On PID4, DCS restored reduced NR2A and increased GluR2 by 54%, and also restored diminished recognition memory in FPI pups. EE significantly improved MWM performance in shams, regardless of treatment. In contrast, FPI-EE-Sal animals only performed to the level of standard housed animals, whereas FPI-EE-DCS animals were comparable with sham-EE counterparts. This study shows that NMDAR agonist use during reduced glutamatergic transmission after developmental TBI can reinstate early molecular and behavioral responses that subsequently manifest in experience-dependent plasticity and rescued potential.

Entities:  

Keywords:  TBI; behavioral assessments; learning and memory; neuroplasticity; receptors

Mesh:

Substances:

Year:  2017        PMID: 27931146      PMCID: PMC5397224          DOI: 10.1089/neu.2016.4747

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  56 in total

1.  Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo.

Authors:  E M Quinlan; B D Philpot; R L Huganir; M F Bear
Journal:  Nat Neurosci       Date:  1999-04       Impact factor: 24.884

Review 2.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

3.  Effects of enriched environment and fluid percussion injury on dendritic arborization within the cerebral cortex of the developing rat.

Authors:  Emily Yu-Yen Ip; Christopher Conrad Giza; Grace Sophia Griesbach; David Allen Hovda
Journal:  J Neurotrauma       Date:  2002-05       Impact factor: 5.269

4.  Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret.

Authors:  E B Roberts; A S Ramoa
Journal:  J Neurophysiol       Date:  1999-05       Impact factor: 2.714

5.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

Review 6.  Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.

Authors:  Keith W Muir
Journal:  Curr Opin Pharmacol       Date:  2005-12-15       Impact factor: 5.547

Review 7.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

8.  Changes in neurotransmitter amino acids and protein in CNS areas of mice subjected to differential housing conditions.

Authors:  F Cordoba; B Yusta; J Muñoz-Blanco
Journal:  Pharmacol Biochem Behav       Date:  1984-09       Impact factor: 3.533

9.  On the delay-dependent involvement of the hippocampus in object recognition memory.

Authors:  Rebecca S Hammond; Laura E Tull; Robert W Stackman
Journal:  Neurobiol Learn Mem       Date:  2004-07       Impact factor: 2.877

10.  What is the Most Sensitive Measure of Water Maze Probe Test Performance?

Authors:  Hamid R Maei; Kirill Zaslavsky; Cátia M Teixeira; Paul W Frankland
Journal:  Front Integr Neurosci       Date:  2009-03-09
View more
  11 in total

1.  Preclinical Western Blot in the Era of Digital Transformation and Reproducible Research, an Eastern Perspective.

Authors:  Saman Sargolzaei; Ajeet Kaushik; Seyed Soltani; M Hadi Amini; Mohammad Reza Khalghani; Navid Khoshavi; Arman Sargolzaei
Journal:  Interdiscip Sci       Date:  2021-06-02       Impact factor: 2.233

Review 2.  Therapeutic strategies to target acute and long-term sequelae of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Neuropharmacology       Date:  2018-06-20       Impact factor: 5.250

3.  Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin.

Authors:  Chun-Shu Piao; Ashley L Holloway; Sue Hong-Routson; Mark S Wainwright
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

4.  Quantification of Biological Responses as Predictors of Cognitive Outcome after Developmental TBI.

Authors:  Saman Sargolzaei; Yan Cai; Deborah Lee; Neil G Harris; Christopher C Giza
Journal:  IEEE EMBS Int Conf Biomed Health Inform       Date:  2018-04-09

5.  Juvenile Traumatic Brain Injury Results in Cognitive Deficits Associated with Impaired Endoplasmic Reticulum Stress and Early Tauopathy.

Authors:  Michael J Hylin; Ryan C Holden; Aidan C Smith; Aric F Logsdon; Rabia Qaiser; Brandon P Lucke-Wold
Journal:  Dev Neurosci       Date:  2018-05-22       Impact factor: 2.984

6.  Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision.

Authors:  Patrick M Kochanek; Travis C Jackson; Ruchira M Jha; Robert S B Clark; David O Okonkwo; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Philip E Empey; Yvette P Conley; Michael J Bell; Anthony E Kline; Corina O Bondi; Dennis W Simon; Shaun W Carlson; Ava M Puccio; Christopher M Horvat; Alicia K Au; Jonathan Elmer; Amery Treble-Barna; Milos D Ikonomovic; Lori A Shutter; D Lansing Taylor; Andrew M Stern; Steven H Graham; Valerian E Kagan; Edwin K Jackson; Stephen R Wisniewski; C Edward Dixon
Journal:  J Neurotrauma       Date:  2019-02-01       Impact factor: 5.269

Review 7.  The Importance of Therapeutic Time Window in the Treatment of Traumatic Brain Injury.

Authors:  Maliheh Mohamadpour; Kristen Whitney; Peter J Bergold
Journal:  Front Neurosci       Date:  2019-01-23       Impact factor: 4.677

8.  Region-Dependent Modulation of Neural Plasticity in Limbic Structures Early after Traumatic Brain Injury.

Authors:  Ann N Hoffman; Sonya Watson; Michael S Fanselow; David A Hovda; Christopher Giza
Journal:  Neurotrauma Rep       Date:  2021-04-08

9.  Blood Glutamate Scavenging With Pyruvate as a Novel Preventative and Therapeutic Approach for Depressive-Like Behavior Following Traumatic Brain Injury in a Rat Model.

Authors:  Dmitry Frank; Benjamin F Gruenbaum; Ilan Shelef; Vladislav Zvenigorodsky; Olena Severynovska; Ron Gal; Michael Dubilet; Alexander Zlotnik; Ora Kofman; Matthew Boyko
Journal:  Front Neurosci       Date:  2022-02-14       Impact factor: 4.677

Review 10.  Bridging the gap: Mechanisms of plasticity and repair after pediatric TBI.

Authors:  Naomi S Sta Maria; Saman Sargolzaei; Mayumi L Prins; Emily L Dennis; Robert F Asarnow; David A Hovda; Neil G Harris; Christopher C Giza
Journal:  Exp Neurol       Date:  2019-05-02       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.